Work

Abstract PO5-19-03: 1st-in-human CAR T targets MUC1 transmembrane cleavage product

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs23-po5-19-03

Authors: Cynthia Bamdad, Joanne Mortimer, Yuan Yuan, Jennifer M. Specht, Benoit Smagghe, Stephen Chi-Min Lin, Andrew Stewart, Danica Walkley, Mark Carter, Timothy Synold, Vishwas Parekh, Kevin Yi, Jac-Leen Nash, Michael Nash, Qing Liu-Michael, Stanley Hamilton, Stephen Forman

Institutions: Minerva Biotechnologies (United States), City Of Hope National Medical Center, City of Hope, Cedars-Sinai Medical Center, University of Washington, Fred Hutch Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396590647

Cites:

Cited by:

Related to: 10